Literature DB >> 26606818

Intracavitary Brachytherapy for Gynecologic Malignancies: Applications and Innovations.

Ashley A Weiner, Julie K Schwarz.   

Abstract

While surgical management is a common approach for gynecologic malignancies; often disease is locally advanced such that surgery is precluded or surgical pathology reveals disease extent that mandates adjuvant treatment. Gynecologic brachytherapy is an important tool for both definitive and adjuvant treatment of cervical and endometrial cancers. Brachytherapy enables high radiation doses to a target with rapid fall-off to protect adjacent normal structures. This paper aims to detail the usage of brachytherapy in gynecologic cancers with a focus on advances in technique.

Entities:  

Mesh:

Year:  2015        PMID: 26606818      PMCID: PMC6167241     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  21 in total

1.  High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells.

Authors:  C G Orton
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-01-01       Impact factor: 7.038

2.  Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional.

Authors:  Kari Tanderup; Patricia J Eifel; Catheryn M Yashar; Richard Pötter; Perry W Grigsby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-07       Impact factor: 7.038

3.  Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study.

Authors:  Patricia J Eifel; Alex Ho; Najma Khalid; Beth Erickson; Jean Owen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-07       Impact factor: 7.038

4.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

Authors:  C W Whitney; W Sause; B N Bundy; J H Malfetano; E V Hannigan; W C Fowler; D L Clarke-Pearson; S Y Liao
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.

Authors:  R A Nout; V T H B M Smit; H Putter; I M Jürgenliemk-Schulz; J J Jobsen; L C H W Lutgens; E M van der Steen-Banasik; J W M Mens; A Slot; M C Stenfert Kroese; B N F M van Bunningen; A C Ansink; W L J van Putten; C L Creutzberg
Journal:  Lancet       Date:  2010-03-06       Impact factor: 79.321

6.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix.

Authors:  P W Grigsby; B A Siegel; F Dehdashti
Journal:  J Clin Oncol       Date:  2001-09-01       Impact factor: 44.544

7.  Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

Authors:  Elizabeth A Kidd; Barry A Siegel; Farrokh Dehdashti; Janet S Rader; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

8.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

9.  Cervical gross tumor volume dose predicts local control using magnetic resonance imaging/diffusion-weighted imaging-guided high-dose-rate and positron emission tomography/computed tomography-guided intensity modulated radiation therapy.

Authors:  Pawel Dyk; Naomi Jiang; Baozhou Sun; Todd A DeWees; Kathryn J Fowler; Vamsi Narra; Jose L Garcia-Ramirez; Julie K Schwarz; Perry W Grigsby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-20       Impact factor: 7.038

10.  Trends in the utilization of brachytherapy in cervical cancer in the United States.

Authors:  Kathy Han; Michael Milosevic; Anthony Fyles; Melania Pintilie; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-07-09       Impact factor: 7.038

View more
  1 in total

1.  Dosimetric comparison of two different applicators and rectal retraction methods used in inverse optimization-based intracavitary brachytherapy for cervical cancer.

Authors:  Fatih Biltekin; Melis Gultekin; Melek Tugce Yilmaz; Ferah Yildiz
Journal:  J Contemp Brachytherapy       Date:  2020-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.